DE602004013695D1 - Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie - Google Patents

Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie

Info

Publication number
DE602004013695D1
DE602004013695D1 DE602004013695T DE602004013695T DE602004013695D1 DE 602004013695 D1 DE602004013695 D1 DE 602004013695D1 DE 602004013695 T DE602004013695 T DE 602004013695T DE 602004013695 T DE602004013695 T DE 602004013695T DE 602004013695 D1 DE602004013695 D1 DE 602004013695D1
Authority
DE
Germany
Prior art keywords
hyperhomocysteinemia
treatment
pharmaceutical composition
disclosed
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004013695T
Other languages
English (en)
Inventor
Sergio Anzalone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medosan Industrie Biochimiche Riunite SpA
Original Assignee
Medosan Industrie Biochimiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Industrie Biochimiche Riunite SpA filed Critical Medosan Industrie Biochimiche Riunite SpA
Publication of DE602004013695D1 publication Critical patent/DE602004013695D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004013695T 2003-09-26 2004-09-22 Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie Expired - Fee Related DE602004013695D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Publications (1)

Publication Number Publication Date
DE602004013695D1 true DE602004013695D1 (de) 2008-06-26

Family

ID=30131588

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004013695T Expired - Fee Related DE602004013695D1 (de) 2003-09-26 2004-09-22 Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie

Country Status (4)

Country Link
EP (1) EP1518554B1 (de)
AT (1) ATE395055T1 (de)
DE (1) DE602004013695D1 (de)
IT (1) ITRM20030442A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110847A1 (it) * 2011-05-13 2012-11-14 Soldato Piero Del Uso di un composto solforato per il trattamento di iperomocisteinemia e patologie correlate
CN105560264A (zh) * 2016-03-11 2016-05-11 广东伊茗药业有限公司 一种含腺苷钴胺的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
DE10004651A1 (de) * 2000-02-03 2001-08-16 Jutta Dierkes Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung

Also Published As

Publication number Publication date
ITRM20030442A0 (it) 2003-09-26
EP1518554B1 (de) 2008-05-14
ATE395055T1 (de) 2008-05-15
ITRM20030442A1 (it) 2005-03-27
EP1518554A1 (de) 2005-03-30

Similar Documents

Publication Publication Date Title
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
EA200700860A1 (ru) (бифенил)карбоновые кислоты и их производные
ATE497495T1 (de) Zur behandlung von neoplastischen erkrankungen, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4- di(phenylamino)pyrimidine
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
EA200401114A2 (ru) Замещённые гидроксиэтиламины
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
EA200401365A1 (ru) Способы лечения илеуса
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
EA200600588A1 (ru) Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
ATE524181T1 (de) Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee